ArticleFrontiers in oncology2022

Survival benefit of thermal ablation therapy for patients with stage II-III non-small cell lung cancer: A propensity-matched analysis.

Wei-Yu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.